
News
After receiving the acquisition offer, Johnson & Johnson-backed Haifu is seeking to sell, aiming for a valuation of over $2.5 billion

After receiving the acquisition offer, Johnson & Johnson-backed Haifu is seeking to sell, aiming for a valuation of over $2.5 billion